|
PJA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.77322609321118E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.54416496151089E-12 |
| Normal-vs-Stage2 |
3.438000E-04 |
| Normal-vs-Stage3 |
3.797600E-03 |
| Normal-vs-Stage4 |
1.567780E-02 |
| Stage1-vs-Stage2 |
5.206600E-01 |
| Stage1-vs-Stage3 |
8.198200E-02 |
| Stage1-vs-Stage4 |
5.103000E-01 |
| Stage2-vs-Stage3 |
4.348800E-01 |
| Stage2-vs-Stage4 |
8.577400E-01 |
| Stage3-vs-Stage4 |
6.546600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.20932169728394E-12 |
| Normal-vs-AfricanAmerican |
2.68600000019603E-08 |
| Normal-vs-Asian |
1.279420E-01 |
| Caucasian-vs-AfricanAmerican |
6.893800E-01 |
| Caucasian-vs-Asian |
7.048600E-01 |
| AfricanAmerican-vs-Asian |
8.139200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.80726569662693E-14 |
| Normal-vs-Female |
2.847400E-04 |
| Male-vs-Female |
2.259100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.67110000013093E-07 |
| Normal-vs-Extreme_Weight |
3.58635343644664E-12 |
| Normal-vs-Obese |
1.05800000005374E-06 |
| Normal-vs-Extreme_Obese |
4.67580000274026E-08 |
| Normal_Weight-vs-Extreme_Weight |
4.523800E-01 |
| Normal_Weight-vs-Obese |
3.416400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.846600E-01 |
| Extreme_Weight-vs-Obese |
4.652100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.169000E-01 |
| Obese-vs-Extreme_Obese |
1.308170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.299700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.8917000016726E-08 |
| Normal-vs-Age(61-80Yrs) |
2.89768209427166E-14 |
| Normal-vs-Age(81-100Yrs) |
2.72349999996813E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.506800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.730200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.700600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.043770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.818820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.342400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.26565424807268E-14 |
| Normal-VS-Type2 PRCC |
2.11230000002338E-06 |
| Normal-VS-KIRP CIMP |
6.23199999999491E-05 |
| Normal-VS-Unclassified PRCC |
2.399400E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.275000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.180200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.247610E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.247200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.119400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.981200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.95709995274041E-09 |
| Normal-vs-N1 |
4.039500E-03 |
| Normal-vs-N2 |
4.463600E-03 |
| N0-vs-N1 |
1.016620E-01 |
| N0-vs-N2 |
7.019600E-01 |
| N1-vs-N2 |
6.829800E-01 |
|
|
